Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference
Pulse Biosciences, Inc. plans to present at the BofA Securities 2026 Healthcare Conference in Las Vegas, scheduled for May 13 at 4:35 pm PT. The presentation will discuss their nPulse™ technology utilizing nanosecond pulsed field ablation (nsPFA™) energy. A live and recorded webcast of the presentation will be accessible on their website.
HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced plans to participate in the upcoming BofA Securities 2026 Healthcare Conference in Las Vegas, NV. Pulse Biosciences’ Management is scheduled to present on Wednesday, May 13, at 4:35 pm PT. A live and recorded webcast of the presentation will be available on the “Events Calendar and Presentations” page of the